$0.10
0.00 (-4.44%)
Open$0.11
Previous Close$0.11
Day High$0.11
Day Low$0.10
52W High$11.00
52W Low—
Volume—
Avg Volume1.87M
Market Cap1.71M
P/E Ratio—
EPS$-141.08
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 398.2K | 400.3K | 406.3K |
| Net Income | -29,112 | -35,289 | -31,464 |
| Profit Margin | -7.3% | -8.8% | -7.7% |
| EBITDA | -48,158 | -49,842 | -45,919 |
| Free Cash Flow | -34,661 | -49,903 | -42,011 |
| Rev Growth | +16.9% | +4.6% | -8.7% |
| Debt/Equity | 0.13 | 0.15 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |